European Society for Medical Oncology (ESMO) 2023 – Abstracts #2362MO and #2359O
Dr. Arlene Siefker-Radtke, Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center in Houston, TX discusses her presentation at ESMO 2023, abstracts #2362MO and #2359O on Erdafitinib (erda) from the Phase 3 THOR study. For more information visit: https://www.annalsofoncology.org/article/S0923-7534(23)04015-2/fulltext and https://www.nejm.org/doi/full/10.1056/NEJMoa2308849
Arlene O Siefker-Radtke, MD is a Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, TX. She is a graduate of The Johns Hopkins University School of Medicine and has been in practice for more than 20 years.
